Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase producing Escherichia coli urinary tract infections

Publication Date

2026

Presented At:

Antimicrobial Stewardship & Healthcare Epidemiology (ASHE)

Content Type

Presentation

Additional Authors:

Margarita Bellon, Stephen Breazeale

This document is currently not available here.

Share

COinS